Silver Book Fact

Annual AFib-related stroke Medicare costs

Stroke in Medicare patients with atrial fibrillation who were not treated with anticoagulants, cost Medicare $4.8 billion each year in direct costs. Those who had strokes despite prophylactic treatment cost an additional $3.1 billion.

Caro J. An Economic Model of Stroke in Atrial Fibrillation: The cost of suboptimal oral anticoagulation. Am J Managed Care. 2004; 10(14): S451-61. https://www.ajmc.com/view/dec04-1992ps451-s461

Reference

Title
An Economic Model of Stroke in Atrial Fibrillation: The cost of suboptimal oral anticoagulation
Publication
Am J Managed Care
Publication Date
2004
Authors
Caro J
Volume & Issue
Volume 10, Issue 14
Pages
S451-61
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • Annual AFib care
    Each year AFib leads to around 350,000 hospitalizations, 5 million office visits, 276,000 emergency department visits, and 234,000 hospital outpatient department visits.  
  • Atrial fibrillation prevalence projection, 2050
    Atrial fibrillation prevalence is projected to rise to between 5.6 and 12.1 million in 2050.  
  • Age as a risk factor of Afib
    At age 60, 1 in 25 Americans have AFib. At age 80+, this increases to nearly 1 in 10.  
  • Average length of stay for major bleeding complications
    The average length of stay for major bleeding complications is six days.  
  • Atrial fibrillation increases stroke risk
    Atrial fibrillation increases the risk of stroke 5- fold.